Gender

Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,688 - - -
Yes 98 - - -
Unknown 18 - - -
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1)) vs Age at Sleep Heart Health Study Visit One (SHHS1)
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 333 1,003 1,746 1,581 923 102 5,688
Yes 3 10 20 34 29 2 98
Unknown 6 4 3 2 3 - 18
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1)) vs Gender of the participant
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,704 2,984 5,688
Yes 50 48 98
Unknown 11 7 18
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1)) vs Race of the participant
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,812 497 379 5,688
Yes 85 13 - 98
Unknown 10 5 3 18